A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

There is yet no established treatment for chronic hepatitis C patients non-responder to standard interferon and ribavirin. To evaluate efficacy and safety of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in such patients. 161 non-responders to standard interferon and ribavir...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alimentary pharmacology & therapeutics 2006-10, Vol.24 (7), p.1079-1086
Hauptverfasser:	Ciancio, A, Picciotto, A, Giordanino, C, Smedile, A, Tabone, M, Manca, A, Marenco, G, Garbagnoli, P, Andreoni, M, Cariti, G, Calleri, G, Sartori, M, Cusumano, S, Grasso, A, Rizzi, R, Gallo, M, Basso, M, Anselmo, M, Percario, G, Ciccone, G, Rizzetto, M, Saracco, G
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Amantadine - therapeutic use Antiviral Agents - therapeutic use Drug Therapy, Combination Follow-Up Studies Hepatitis C, Chronic - drug therapy Humans Interferon-alpha - therapeutic use Middle Aged Polyethylene Glycols - therapeutic use Recombinant Proteins Ribavirin - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!